OncoCyte Corporation (OCX) Earnings
|
Expand Research on OCX
| Next EPS Date | N/A | EPS Growth Rate | +42.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | -0.7% *Last Qtr. |
| Average % Move 1-Wk after EPS | -7.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/24/25 | Q424 | -$1.93 | $0.00 | -$1.93 | $1.49M | N/A | N/A |  | | Details | |
| 11/12/24 | Q324 | -$0.98 | $0.00 | -$0.98 | $110K | N/A | N/A | | | Details | |
| 8/8/24 | Q224 | -$0.36 | $0.00 | -$0.36 | $100K | N/A | N/A | | | Details | |
| 5/15/24 | Q124 | -$1.13 | $0.00 | -$1.13 | $180K | N/A | N/A | | | Details | |
| 4/12/24 | Q423 | -$3.37 | N/A | N/A | $1.5M | N/A | N/A | | | Details | |
| 11/16/23 | Q323 | N/A | -$1.13 | N/A | N/A | $437.5K | N/A | N/A | N/A | ||
11/9/23  |
Q323 | -$0.81 | -$1.13 | +$0.32 | $430K | $437.5K | N/A | | | Details | |
| 8/16/23 | Q223 | N/A | -$1.30 | N/A | N/A | $362.5K | N/A | N/A | N/A |
